Drugs.com Twitter
En EspanolEn Espanol

Search Results - Page 1 of about 229 results

Acomplia (rimonabant) is the first in a new class of therapeutic agents called Cannabinoid-1 Receptor Blockers (CB1). Acomplia is used in the treatment of obesity and related conditions. How does Acomplia work? Acomplia acts by selectively blocking CB1 receptors found in the brain and in peripheral organs...
User Reviews
Support Group Q & A
User Reviews for Acomplia. The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for ...
User Reviews (Drugs.com)
Ask questions and get answers about Acomplia. Our support group helps people share their own experience. 7 members.
Drugs Questions & Answers (Drugs.com)
Zimulti (rimonabant) is a new drug in development for the treatment of obesity and overweight patients with associated risk factors. Zimulti information includes news, clinical ...
New Drug Applications (FDA)
Zimulti (rimonabant) is a new drug in development for the treatment of obesity and overweight patients with associated risk factors. Zimulti information includes news, clinical ...
New Drug Applications (FDA)
Acomplia (rimonabant) receives marketing authorisation in the European Union (PDF) sanofi-aventis Press Release June 21, 2006 FDA Advisory Committee Did Not Recommend Approval of ...
Consumer Information (Drugs.com)
1 Answer - Posted in support group: acomplia - Answer: Acomplia (rimonabant) is the first in a new class of therapeutic agents ...
Drugs Questions & Answers (Drugs.com)
Taking the investigational drug rimonabant (brand name Acomplia) produces modest, sustained weight loss and improved blood markers after two years, according to
News & Articles (Drugs.com)
217 medications are known to interact with Tenuate Dospan. Includes Acomplia (rimonabant), Adderall XR (amphetamine/dextroamphetamine), amitriptyline.
Drug Interactions (Cerner Multum)
Listing New Drug Applications filed with the United States Federal Drug Administration (FDA) from 2004 to present date.
www.drugs.com/nda.html
1 2 3 4 5 6 7 8 9 10
(web9)